Identification of the prognostic value of immune gene signature and infiltrating immune cells for esophageal cancer patients.

CONCLUSION: Our study indicated that the immune-related prognostic signature could serve as a novel biomarker for predicting patients' prognosis and providing new immunotherapy targets in ESCA.
PMID: 32707495 [PubMed - as supplied by publisher]

Source: International Immunopharmacology - July 20, 2020 Category: Allergy & Immunology Authors: Wang L, Wei Q, Zhang M, Chen L, Li Z, Zhou C, He M, Wei M, Zhao L Tags: Int Immunopharmacol Source Type: research